XT
AVXL icon

XTX Topco’s Anavex Life Sciences AVXL Stock Holding History

XTX Topco’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.7K Sell
32,716
-225,355
-87% -$667K ﹤0.01% 3575
2026
Q1 		$792K Buy
258,071
+159,013
+161% +$689K 0.01% 1623
2025
Q4 		$353K Buy
99,058
+17,356
+21% +$106K 0.01% 1931
2025
Q3 		$727K Buy
+81,702
New +$829K 0.04% 793
2025
Q1 		– Sell
-52,344
Closed -$562K – 2409
2024
Q4 		$562K Buy
+52,344
New +$403K 0.05% 673
2023
Q3 		– Sell
-21,423
Closed -$174K – 1557
2023
Q2 		$174K Buy
21,423
+8,212
+62% +$70.4K 0.03% 1052
2023
Q1 		$113K Sell
13,211
-25,076
-65% -$250K 0.02% 1077
2022
Q4 		$355K Buy
+38,287
New +$409K 0.08% 480

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

XTX Topco's AVXL Position: Q2 2026 in Review

XTX Topco reduced its Anavex Life Sciences (AVXL) stake by 87% in Q2 2026, selling an estimated $667K and leaving 32,716 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3575.

XTX Topco first reported a position in AVXL in Q4 2022 and has held it in 8 quarters since. The position peaked at $792K in Q1 2026. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • XTX Topco held 32,716 shares of Anavex Life Sciences worth $84.7K as of Q2 2026.
  • XTX Topco sold 225,355 Anavex Life Sciences shares in Q2 2026, an estimated $667K.
  • Anavex Life Sciences made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3575 holding.
  • XTX Topco first reported a position in Anavex Life Sciences in Q4 2022 and has held it in 8 quarters since.
  • XTX Topco's Anavex Life Sciences position peaked at $792K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.